1. Home
  2. SGHT vs DOMO Comparison

SGHT vs DOMO Comparison

Compare SGHT & DOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

N/A

Current Price

$3.64

Market Cap

282.9M

Sector

Health Care

ML Signal

N/A

Logo Domo Inc. Class B

DOMO

Domo Inc. Class B

N/A

Current Price

$4.70

Market Cap

189.3M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
SGHT
DOMO
Founded
2011
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
282.9M
189.3M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
SGHT
DOMO
Price
$3.64
$4.70
Analyst Decision
Buy
Buy
Analyst Count
7
10
Target Price
$9.08
$11.15
AVG Volume (30 Days)
362.9K
1.5M
Earning Date
06-01-2026
06-10-2026
Dividend Yield
N/A
N/A
EPS Growth
28.16
N/A
EPS
N/A
N/A
Revenue
$77,363,000.00
$317,044,000.00
Revenue This Year
$13.54
$4.66
Revenue Next Year
$14.53
$7.89
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.03
$3.45
52 Week High
$9.24
$18.49

Technical Indicators

Market Signals
Indicator
SGHT
DOMO
Relative Strength Index (RSI) 28.77 50.39
Support Level $3.26 $4.51
Resistance Level $3.70 $6.62
Average True Range (ATR) 0.34 0.39
MACD -0.11 0.22
Stochastic Oscillator 2.50 65.46

Price Performance

Historical Comparison
SGHT
DOMO

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

Share on Social Networks: